Investing
For the first decade-plus of Bitcoin’s existence, crypto managed to avoid becoming a political issue, with figures in both parties warming up to what...
Hi, what are you looking for?
Repay Down
Investing
Cisco Systems Inc. gave some more details on the timing of revenue from its anticipated orders related to artificial intelligence, and it looks like...
Investing
Long-term investors have been well served by index funds, which often charge very low fees and can be hard for active portfolio managers to...
Investing
If you see a headline that a company beat analysts’ expectations when reporting its quarterly results, it may not mean very much. The analysts...
Investing
U.S. airlines are bracing for a travel surge this summer, hoping for a smoother season after last summer was marred by delays and cancellations,...
Investing
Amid Target’s decision to pull Pride-themed products from some stores after intense anti-LGBTQ backlash, many of its employees believe the company has caved to...
Investing
For the first time ever, an all-electric vehicle — the Tesla Model Y — is now the world’s bestselling car. According to analyst data...
Investing
Social-media platforms pose “a profound risk of harm to the mental health and well-being of children,” and there is not enough evidence “to determine...
Investing
Although they are marketed as having no fees and no interest, some buy now, pay later products do include such charges — but it...
Investing
Oil futures settle higher on Friday, contributing to a gain for the week, as investors weighed prospects for further cuts in crude production when...
Investing
By Mary de Wet StoneCo promoted Vice President of Finance Mateus Scherer Schwening to the role of chief financial officer. Scherer joined StoneCo as...
Investing
By Stephen Nakrosis GEN Restaurant Group, which owns 32 restaurants offering traditional Korean and Korean-American food, filed for an initial public offering on Friday...
Investing
By Mary de Wet Iovance Biotherapeutics shares rose 15% in after-hours trade Friday after the company’s biologics license application for lifileucel to treat advanced...
